We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Drug Sponge Could Minimize Cancer Treatment Side Effects

News   Jan 09, 2019 | Original story by Robert Sanders for UC Berkeley

 
Drug Sponge Could Minimize Cancer Treatment Side Effects

Liver cancer treatment has advanced from intravenous delivery of chemotherapy drugs, which affects not only the tumor and liver but also organs throughout the body (red, left), to intra-arterial chemo (center), which limits the spread of the drug, though up to half can still exit the liver to poison the rest of the body. The proposed absorber would sop up unused drug emerging from the liver, drastically reducing unwanted effects on other organs (right). Credit: Anand Patel, MD, UCSF

 
 
 

RELATED ARTICLES

Safety and Efficacy Results From CRISPR/Cas9 Human Clinical Trials Are Positive

News

CRISPR Therapeutics and Vertex Pharmaceuticals have announced their interim safety and efficacy results from the CTX001 CRISPR/Cas9 gene-editing human clinical trials - and they're promising.

READ MORE

A Milestone Is Reached For New Leukemia Drug

News

Cold Spring Harbor Laboratory scientists, with chemists and cancer biologists from Dana-Farber Cancer Institute (DFCI), have developed a new therapy that extended the survival of mice with acute myeloid leukemia.

READ MORE

New Database Could Help Identify Therapeutic Targets for the Creation of Antibiotics

News

Researchers have created a database called "BacFITBase" which characterizes bacterial genes relevant to the infection process in live organisms. The new database aims to aid the discovery of novel therapeutic targets for the creation of antibiotics.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Cancer Research

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE